Marker Therapeutics clinical trials we track

Check company identity source

Phase 2 1 trial

TrialDrugs studiedStatusPrimary completion
Efficacy of MT-401 in Patients With AML Following Stem Cell TransplantNCT04511130MT-401Terminated2024-03-01Actual

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.